What You Should Know: Today, OM1 announced the launch of its Parkinson’s Disease datasets, enhancing its Mental Health & Neuroscience Real-World Data Network.OM1’s Mental Health & Neuroscience Real-World Data Network, which already includes robust datasets focused on Major Depressive Disorder, Multiple Sclerosis, Bipolar Disorder I and Schizophrenia, will further expand to include Alzheimer’s Disease in the coming months. Parkinson’s Disease Premium Dataset Nearly
Read More
Parkinson's Disease
The Case for Incorporating Patient Perspectives into Clinical Decision Support
A recent report from the Leapfrog Group found that patient experience scores at hospitals declined during the pandemic. This should be no surprise. Hospitals faced an incredible crucible during COVID-19, with many still experiencing high levels of stress in their systems. In addition to increasing demands on caregivers, the pandemic created a fundamental change in how patients are treated. The drive to telehealth was rapidly accelerated, transforming traditional in-person interactions between
Read More
PreciseDx’s AI-Enabled Digital Pathology Proven to Detect Early-Stage Parkinson’s Disease
What You Should Know: - Mount Sinai spinout, PreciseDx, today announced that its AI-enabled digital pathology is the first proven to detect early-stage Parkinson’s disease, according to a recent research study. - The study, conducted in collaboration with Michael J. Fox Foundation, identified that PreciseDx’s technology can accurately diagnose Parkinson's disease in living patients prior to the severe onset of symptoms. Challenges Diagnosing Parkinson’s
Read More
Medtronic Launches FDA-Approved Deep Brain Stimulation Device in U.S.
- Samsung and Medtronic unveils new state of the art FDA-approved Deep Brain Stimulation (DBS) device that uses a surgically implanted medical stimulator to deliver electric pulses directly to the brain.- Rather than using a bulky medical device, the Medtronic DBS solution allows patients to manage their therapy more discreetly and actually can reduce the need for regular doctor visits through more streamlined coordination directly with clinicians.Medtronic announced the U.S. launch of its
Read More
Alphabet and Michael J. Fox Foundation Team Up to Use Verily Study Watch to Research Parkinson’s Disease
The Michael J. Fox Foundation for Parkinson's Research (MJFF) and Verily Life Sciences LLC, an Alphabet company has announced a new collaboration on a two-year sub-study in Parkinson's Progression Markers Initiative will include Verily Study Watch to add new dimension of health data. More than 800 participants will be equipped with Verily's multi-sensor investigational wearable device, to passively collect data on movement and physiologic and environmental measures continuously. The goal is to
Read More
